INTERCEPT PHARMACEUTICALS, INC.·4

Oct 31, 7:00 PM ET

Bright Lisa 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Oct 31, 2019

Insider Transaction Report

Form 4
Period: 2019-10-29
Bright Lisa
CCO & Corp Affairs Officer
Transactions
  • Sale

    Common Stock

    2019-10-29$75.00/sh595$44,62518,732 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.

Documents

1 file
  • 4
    tm1921520d1_4.xmlPrimary

    OWNERSHIP DOCUMENT